Inhibition of Fibrin Polymerization by Serum Amyloid P Component and Heparin

Summary

The effects of serum amyloid P component (SAP) and heparin on the thrombin-catalyzed formation of polymeric fibrin from purified fibrinogen were examined using a turbidometric method to quantify fibrin polymerization. SAP and heparin acted synergistically to inhibit the lateral aggregation of fibrin fibrils, resulting in the formation of fibrils with a smaller mass to length ratio. Heparin did not enhance the incorporation of SAP into fibrin clots, and the effect of heparin and SAP did not seem to be related to inhibition of thrombin or of fibrinopeptide release. The evidence suggests that a soluble complex of SAP and heparin inhibits fibrin polymerization.

Keywords

Amyloid P component - Heparin - Fibrin polymerization

• References

• 1 Pepys M. et al Biology of serum amyloid P component. Ann NY Acad Sci 1982; 102: 286
• 2 Pepys M. et al Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component. Nature 1978; 273: 168-170
• 3 Robey F, Tanaka T, Liu T. Isolation and characterization of two major serum proteins from the dogfish, Mustelus canis, C-reactive protein and amyloid P component. J Biol Chem 1983; 258: 3889-3894
• 4 Pinteric L, Assimeh S, Kells D, Painter R. The ultrastructure of C1t, a subcomponent of the first component of complement: an E. M. and ultracentrifuge study. J Immunol 1976; 117: 79-83
• 5 Baltz M, De Beer F, Feinstein A, Pepys M. Calcium-dependent aggregation of human serum amyloid P component. Biochim Biophys Acta 1982; 701: 229-236
• 6 Hind C, Collins P, Baltz M, Pepys M. Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4.6-pyruvate acetal of galactose. Biochem J 1985; 225: 107-111
• 7 Pollak A, Coradello H, Latzka U, Lischka A, Lubec G. Wechselwirkungen zwischen Amyloid P und Bindegewebsproteinen. Klin Wochenschr (Vienna) 1982; 94: 291-293
• 8 Ku C, Fiedel B. Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin. J Exp Med 1983; 158: 767-780
• 9 Bale M, Mosher D. Effects of thrombospondin on fibrin polymerization and structure. J Biol Chem 1986; 261: 862-868
• 10 Pepys M. et al Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet 1977; 1: 1029-1031
• 11 Mosher D, Vaheri A. Thrombin stimulates the production and release of a major surface-associated glycoprotein (fibronectin) in cultures of human fibroblasts. Exp Cell Res 1978; 112: 323-334
• 12 Mosher D, Blout E. Heterogeneity of bovine fibrinogen and fibrin. J Biol Chem 1975; 248: 6896-6903
• 13 Kazama M, McDonagh J, Wagner R, Landell R, McDonagh R. Purification and immunochemical characterization of human plasma factor XIII. Haemostasis 1976; 5: 329-340
• 14 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature (Lond) 1970; 277: 680-685
• 15 Carr M, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules 1978; 11: 46-50
• 16 Carr M, Shen L, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers 1977; 16: 1-15
• 17 Hansen B, Hutchcraft C, Gewurz H. Interaction of serum amyloid P-component with heparin. Fed Proc 1982; 41: 560 (Abstr)